Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment
- PMID: 16961764
- DOI: 10.1111/j.1369-1600.2006.00033.x
Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment
Abstract
The Fawn-Hooded rat (FH/Wjd) is an inbred alcohol-preferring rat strain, unlike most of the other strains that were selectively bred for high alcohol intake and preference. It was chosen for study some 16 years ago because of a reported mutation that disrupted platelet serotonin function. Although the FH/Wjd rat has high alcohol intake (>5 g/kg/day) and preference (>65%), interbreeding with an alcohol-non-preferring inbred strain suggested that these measures are unrelated to the serotonin abnormality. Similarly, the exaggerated immobility of the FH/Wjd rats in the forced swim test did not correlate with the high alcohol intake. Many compounds have been tested in the FH/Wjd rats after both acute and chronic treatment and a substantial number of them have proved effective. However, as the case with opiate antagonists, tolerance to the effects of the drug can develop. An up-regulation of opioid receptors accompanied the chronic treatment and this mechanism may account for the development of tolerance. Tolerance to opiate antagonists has also been demonstrated in two of the selectively bred alcohol-preferring rat lines, but it is unknown whether this process may contribute to the relapses seen in individuals being treated with naltrexone. Other drugs that reliably decrease alcohol intake in the FH/Wjd rats include the 5-hydroxytryptamine-2A receptor antagonist, amperozide, the mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) and herbal derivatives such as ibogaine, St. John's wort and kudzu extract. Thus, studies in the FH/Wjd rat have led to the discovery of a wide variety of targets for the development of novel agents to treat alcoholism. The fact that several of these drugs were shown to reduce alcohol intake in some of the selectively bred alcohol-preferring rat lines and/or alcohol-preferring vervet monkeys increases our confidence that they are good candidates for further development.
Similar articles
-
Depressive-like behavior and high alcohol drinking co-occur in the FH/WJD rat but appear to be under independent genetic control.Neurosci Biobehav Rev. 2007;31(1):103-14. doi: 10.1016/j.neubiorev.2006.07.002. Epub 2006 Sep 18. Neurosci Biobehav Rev. 2007. PMID: 16982094 Review.
-
Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974.Alcohol Clin Exp Res. 1997 Nov;21(8):1448-54. Alcohol Clin Exp Res. 1997. PMID: 9394117
-
Analysis of alcohol-related phenotypes in F2 progeny derived from FH/Wjd and ACI/N rat strains reveals independent measures and sex differences.Behav Brain Res. 2007 Feb 12;177(1):37-44. doi: 10.1016/j.bbr.2006.11.008. Epub 2006 Dec 11. Behav Brain Res. 2007. PMID: 17161877
-
The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism.Psychiatr Genet. 2002 Mar;12(1):1-16. doi: 10.1097/00041444-200203000-00001. Psychiatr Genet. 2002. PMID: 11901354 Review.
-
Reduced 5-HT3 receptor binding and lower baseline plus maze anxiety in the alcohol-preferring inbred fawn-hooded rat.Pharmacol Biochem Behav. 2004 Feb;77(2):281-9. doi: 10.1016/j.pbb.2003.11.015. Pharmacol Biochem Behav. 2004. PMID: 14751456
Cited by
-
Neuropharmacology of alcohol addiction.Br J Pharmacol. 2008 May;154(2):299-315. doi: 10.1038/bjp.2008.30. Epub 2008 Mar 3. Br J Pharmacol. 2008. PMID: 18311194 Free PMC article. Review.
-
Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.Recent Pat CNS Drug Discov. 2012 Aug;7(2):93-112. doi: 10.2174/157488912800673155. Recent Pat CNS Drug Discov. 2012. PMID: 22574678 Free PMC article.
-
Rat animal models for screening medications to treat alcohol use disorders.Neuropharmacology. 2017 Aug 1;122:201-243. doi: 10.1016/j.neuropharm.2017.02.004. Epub 2017 Feb 16. Neuropharmacology. 2017. PMID: 28215999 Free PMC article. Review.
-
Pre-Clinical Studies with D-Penicillamine as a Novel Pharmacological Strategy to Treat Alcoholism: Updated Evidences.Front Behav Neurosci. 2017 Mar 7;11:37. doi: 10.3389/fnbeh.2017.00037. eCollection 2017. Front Behav Neurosci. 2017. PMID: 28326026 Free PMC article. Review.
-
The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats.Alcohol Clin Exp Res. 2012 Dec;36(12):2157-67. doi: 10.1111/j.1530-0277.2012.01845.x. Epub 2012 Jun 4. Alcohol Clin Exp Res. 2012. PMID: 22671516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous